Evolva - Evolving the sales model
Evolva has signed a distribution agreement to jointly develop the Brazilian market for resveratrol with its new partner, Tovani Benzaquen, a...
Evolva - A new era
Evolva’s FY21 revenues of CHF9.9m were below our forecast of CHF14.1m as the pandemic continued to stifle momentum during H2. Flavours and...
Evolva - A new CEO for a new phase of growth
Evolva has appointed Christian Wichert as its new CEO to accelerate growth and lead the company during its next phase. Over the last 18 months...
Evolva - Updating estimates
On 30 November, Evolva announced a private placement whereby Veraison SICAV would purchase 63.75m shares at CHF0.118 per share, or a 7% discount to...
No more insights